Granite Ridge Resources, Inc. (GRNT)
Live price chart, market sentiment, and community perspectives for Granite Ridge Resources, Inc. (NYSE: GRNT).
Live price chart, market sentiment, and community perspectives for Granite Ridge Resources, Inc. (NYSE: GRNT).
Looking at the Q2 2026 numbers, management is guiding toward a 2027 free cash flow inflection, underpinning a 10% FCF yield at $65 oil. However, the current shift from traditional non-op working interests into operated partnerships needs careful execution to ensure debt-funded dividends don't swamp equity value before free cash flow actually turns positive.
When evaluating GRNT's operating model, pay close attention to cost pressures. Lease operating expenses hit $10.27 per Boe ($30 million total) in Q2 due to rising Permian water handling costs and early life pad expenses, though management is targeting a reset down to $8.25–$9.25 per Boe moving forward.
From a risk management standpoint, GRNT looks vulnerable. Derivative hedges are deeply underwater with potential losses reaching $70 million if oil prices stay elevated. Combined with annual interest costs consuming $41.2 million, the 9.4% forward dividend yield feels heavily reliant on debt rather than organic cash flow generation.
On our desk, the valuation argument is a central talking point. GRNT trades at an enterprise-value multiple of roughly 2.7x, which sits below many mid-cap and Permian peers. Bulls argue this creates room for a multiple rerate once cash flow targets are met, but skeptics emphasize that heavy debt loads justify the discount.
Tracking the balance sheet metrics: Q2 2026 net income rose to $30.0 million ($0.23 per diluted share) compared to $25.1 million in Q2 2025, while Adjusted EBITDAX ticked up to $79.6 million. Even so, capital expenditures remain heavy, with $78.5 million invested in drilling and completions plus $16.7 million in acquisitions during the quarter.
Analyst consensus is deeply fractured. Some ratings lean toward a Sell due to unsustainable leverage and heavy reliance on debt-backed distributions, while others emphasize that 2026 is planned as the final year of investing ahead of free cash flow before reaping the benefits of their 7.2 net wells turned in line during Q2.
Explore plasma cleansing, somatic organ swaps, and BCI.